References
- Kanev PM, Sheehan JM. Reflections on shunt infection. Pediatr Neurosurg 2003;39(6):285–90.
- Bayston R, Grove N, Siegel J, Lawellin D, Barsham S. Prevention of hydrocephalus shunt catheter colonisation in vitro by impregnation with antimicrobials. J Neurol Neurosurg Psychiatry 1989;52(5):605–9.
- Bayston R, Lambert E. Duration of protective activity of cerebrospinal fluid shunt catheters impregnated with antimicrobial agents to prevent bacterial catheter-related infection. J Neurosurg 1997;87(2):247–51.
- Govender ST, Nathoo N, van Dellen JR. Evaluation of an antibiotic-impregnated shunt system for the treatment of hydrocephalus. J Neurosurg 2003;99(5):831–9.
- Richards H, Seeley H, Pickard J. Do antibiotic-impregnated shunt catheters reduce shunt infection? Data from the UK Shunt Registry. Cerebrospinal Fluid Res 2006;3(Suppl 1):S55.
- Kan P, Kestle J. Lack of efficacy of antibiotic-impregnated shunt systems in preventing shunt infections in children. Childs Nerv Syst 2007;23(7):773–7.
- Ritz R, Roser F, Morgalla M, Dietz K, Tatagiba M, Will BE. Do antibiotic-impregnated shunts in hydrocephalus therapy reduce the risk of infection? An observational study in 258 patients. BMC Infect Dis 2007;7:38.
- Albanese A, De Bonis P, Sabatino G, Antibiotic-impregnated ventriculo-peritoneal shunts in patients at high risk of infection. Acta Neurochirurgica 2009;151(10):1259–63.
- Hayhurst C, Cooke R, Williams D, Kandasamy J, O'Brien DF, Mallucci CL. The impact of antibiotic-impregnated catheters on shunt infection in children and neonates. Childs Nerv Syst 2008;24(5):557–62.
- Parker SL, Attenello FJ, Sciubba DM, Comparison of shunt infection incidence in high-risk subgroups receiving antibiotic-impregnated versus standard shunts. Childs Nerv Syst 2009;25(1): 77–83; discussion 85.
- Kandasamy J, Dwan K, Hartley JC, Antibiotic-impregnated ventriculoperitoneal shunts-a multi-centre British paediatric neurosurgery group (BPNG) study using historical controls. Childs Nerv Syst 2011;27(4):575–81.
- Bayston R. Analysis of twenty-four “failures” of Bactiseal™ antimicrobial shunts reported to FDA. Cerebrospinal Fluid Res 2006;3(Suppl 1):S53.
- Elliott SP, Yogev R, Shulman ST. Staphylococcus lugdunensis: an emerging cause of ventriculoperitoneal shunt infections. Pediatr Neurosurg 2001;35(3):128–30.